Destiny Hinton

The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.

A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.

The 2022 St. Jude Global Alliance Convening brought together researchers from around the globe working to advance cures for children with catastrophic childhood diseases.

Stacey Ogden, PhD, shares mentoring advice for scientists setting up their first laboratory as a principal investigator.

Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.

Research suggests the influence of STEM teachers on the STEM identities and attitudes of elementary school students extend to after-school STEM clubs.

St. Jude scientists have created the first model that faithfully recapitulates details of pediatric bone marrow failure.

SAFER Ukraine, a global humanitarian effort to save Ukrainian children with cancer and blood disorders began spontaneously in a digital meeting room within hours of the invasion. Existing networks fueled its growth.

Microcephaly is a rare neurodevelopmental condition in which a baby’s head is much smaller than expected because the brain did not develop properly or stopped developing during pregnancy. St. Jude researchers identified cells in the outer radial glia in the developing brain that play an important role in microcephaly.

The incidence of pediatric and adult liver cancer is increasing worldwide. Research suggests how premature birth may influence the risk for children.